Lundberg J M, Anggård A, Fahrenkrug J
Acta Physiol Scand. 1982 Mar;114(3):329-37. doi: 10.1111/j.1748-1716.1982.tb06992.x.
The effects of local intraarterial infusions of VIP, acetylcholine (ACh), substance P, isoprenaline and bradykinin on submandibular gland blood flow and salivary secretion were studied in cats. It was found that VIP (10(-14) to 10(-10) mol/min) caused an atropine resistant vasodilation but no salivary secretion. Several hundred fold higher doses of exogenous VIP had to be infused than the amounts of VIP seen in the venous outflow during maximal nerve stimulation at a similar vasodilatory response. ACh infusions (5 X 10(-12) to 5 X 10(-8) mol/min) caused both a muscarinic vasodilation and salivary secretion. ACh was about 100 times less potent than VIP as a vasodilating agent. Both ACh and VIP induced in high doses a vasodilatory response similar to that seen during parasympathetic nerve stimulation at 15 Hz. ACh by itself did in the present doses, however, only induce about 50-60% of the maximal secretory response. Combined infusions of ACh and VIP, had mostly an additive effect on vasodilation. The salivatory volume response to ACh was potentiated by VIP and to a smaller extent also by isoprenaline. This potentiating effect may be due to a direct effect on secretory elements as well as partly to the additional increase in blood flow. Bradykinin was about 1 000 times less potent than VIP as a vasodilating agent. Substance P (10(-9) mol/min) only caused a weak vasodilation. Since there is evidence that ACh and VIP coexist within the same neurons and are both released upon parasympathetic nervous activation, the present findings suggest that the secretory and vasodilatory responses may be caused by an interaction between these two agents.
研究了在猫身上局部动脉内输注血管活性肠肽(VIP)、乙酰胆碱(ACh)、P物质、异丙肾上腺素和缓激肽对下颌下腺血流和唾液分泌的影响。发现VIP(10⁻¹⁴至10⁻¹⁰摩尔/分钟)引起阿托品抵抗性血管舒张,但无唾液分泌。在产生类似血管舒张反应时,与最大神经刺激时静脉流出物中所见的VIP量相比,必须输注数百倍剂量的外源性VIP。输注ACh(5×10⁻¹²至5×10⁻⁸摩尔/分钟)可引起毒蕈碱样血管舒张和唾液分泌。作为血管舒张剂,ACh的效力比VIP低约100倍。高剂量的ACh和VIP均可诱导出类似于15赫兹副交感神经刺激时所见的血管舒张反应。然而,在目前的剂量下,ACh本身仅诱导出约50 - 60%的最大分泌反应。联合输注ACh和VIP,对血管舒张大多具有相加作用。VIP增强了对ACh的唾液分泌量反应,异丙肾上腺素在较小程度上也有增强作用。这种增强作用可能是由于对分泌成分的直接作用以及部分由于血流量的额外增加。作为血管舒张剂,缓激肽的效力比VIP低约1000倍。P物质(10⁻⁹摩尔/分钟)仅引起微弱的血管舒张。由于有证据表明ACh和VIP共存于同一神经元内,且在副交感神经激活时均会释放,目前的研究结果表明,分泌和血管舒张反应可能是由这两种物质之间的相互作用引起的。